XML 38 R23.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Segment Information
 6 Months Ended
Jun. 30, 2024
Segment Reporting [Abstract]  
Segment Information Segment Information
Engineered
Materials		Acetyl
Chain		Other
Activities		EliminationsConsolidated
(In $ millions)
Three Months Ended June 30, 2024
Net sales1,467 1,202 — (18)(1)2,651 
Other (charges) gains, net (Note 18)
(43)(1)(4)— (48)
Operating profit (loss)138 242 (130)— 250 
Equity in net earnings (loss) of affiliates
47 3 1 — 51 
Depreciation and amortization121 61 10 — 192 
Capital expenditures41 36 10 — 87 (2)
Three Months Ended June 30, 2023
Net sales
1,585 1,233 — (23)(1)2,795 
Other (charges) gains, net (Note 18)
(8)— (2)— (10)
Operating profit (loss)
158 295 (118)— 335 
Equity in net earnings (loss) of affiliates
18 2 3 — 23 
Depreciation and amortization
112 54 6 — 172 
Capital expenditures
58 67 27 — 152 (2)
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes a decrease in accrued capital expenditures of $18 million and an increase of $7 million for the three months ended June 30, 2024 and 2023, respectively.
Engineered
Materials		Acetyl
Chain		Other
Activities		EliminationsConsolidated
(In $ millions)
Six Months Ended June 30, 2024
Net sales2,845 2,463 — (46)(1)5,262 
Other (charges) gains, net (Note 18)
(54)(1)(7)— (62)
Operating profit (loss)227 496 (263)— 460 
Equity in net earnings (loss) of affiliates
96 5 5 — 106 
Depreciation and amortization268 118 27 — 413 
Capital expenditures78 76 38 — 192 (2)
As of June 30, 2024
Goodwill and intangible assets, net
10,325 418 — — 10,743 
Total assets
17,470 5,424 2,918 — 25,812 
Six Months Ended June 30, 2023
Net sales
3,215 

2,483 

— (50)(1)5,648 
Other (charges) gains, net (Note 18)
(29)(1)(3)— (33)
Operating profit (loss)
270 573 (257)— 586 
Equity in net earnings (loss) of affiliates
29 3 6 — 38 
Depreciation and amortization
224 108 12 — 344 
Capital expenditures
103 118 39 — 260 (2)
As of December 31, 2023
Goodwill and intangible assets, net
10,525 427 — — 10,952 
Total assets
17,930 5,538 3,129 — 26,597 
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes a decrease in accrued capital expenditures of $50 million and $49 million for the six months ended June 30, 2024 and 2023, respectively.